Harvard Bioscience Inc (HBIO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	6.08% 20.45	21.77	24.56	21.97	23.10
Cost Of Revenue	7.02% 8.917	9.59	10.54	9.205	9.879
Gross Profit	5.34% 11.53	12.18	14.01	12.77	13.22
Operating Expenses	80.03% 12.35	61.85	14.00	14.64	15.29
Benefits Costs and Expenses	68.71% 22.70	72.57	23.97	26.46	26.38
Costs And Expenses	68.71% 22.70	72.57	23.97	26.46	26.38
Operating Income/Loss	98.35% -0.819	-49.67	0.011	-1.874	-2.069
Nonoperating Income/Loss	27.44% -1.435	-1.126	0.579	-2.617	-1.211
Income/Loss From Continuing Operations Before Tax	95.56% -2.254	-50.79	0.59	-4.491	-3.28
Income Tax Expense/Benefit	106.17% 0.028	-0.454	0.572	0.311	-0.353
Income/Loss From Continuing Operations After Tax	95.47% -2.282	-50.34	0.018	-4.802	-2.927
Net Income/Loss	95.47% -2.282	-50.34	0.018	-4.802	-2.927
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.47% 44.30	44.10	0.039	43.61	43.49
Diluted Average Shares	0.47% 44.30	44.10	0.039	43.61	43.49
Basic Earnings Per Share	95.61% -0.05	-1.14	0.010	-0.11	-0.07
Diluted Earnings Per Share	95.61% -0.05	-1.14	0.010	-0.11	-0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALGN

$134.70

1.77%

BAX

$23.58

0.17%

SOLV

$72.38

1.37%

COO

$68.00

1.28%

HOLX

$66.39

0.23%

WST

$247.54

0.57%